Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate CancerFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorderActive, not recruitingPhase 1 / Phase 22026-08-18NCT05067140

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Carolina Urologic Research CenterMyrtle BeachUnited States55
Chesapeake Urology AssociatesBaltimoreUnited States1
City of Hope National MedicalDuarteUnited States5
Florida Cancer SpecialistsFort MyersUnited States15
Fox Chase Cancer CenterPhiladelphiaUnited States259
Karmanos Cancer InstituteDetroitUnited States153
Massachusetts General HospitalBostonUnited States1015
Providence Saint Johns Health CtrSanta MonicaUnited States4
Roswell Park Cancer InstituteBuffaloUnited States9
Scri Oncology PartnersNashvilleUnited States156
Univ of Pittsburgh Cancer InstPittsburghUnited States1
University of California San Diego - Moores Cancer CenterLa JollaUnited States3
University of Virginia Medical CenterCharlottesvilleUnited States30
University of Wisconsin Paul P Carbone Comp Cancer CenterMadisonUnited States2
Urology San AntonioSan AntonioUnited States17
Virginia Cancer SpecialistsFairfaxUnited States109
Yale Cancer CenterNew HavenUnited States31